The expression of Krüppel-like factor 2 (KLF2) activated by resveratrol or statins in LSECs repairs endothelial dysfunction while deactivating HSCs (Gracia-Sancho et al., 2010; Marrone et al., 2013). Here, KLF2 is linked to endothelial dysfunction.